DE60035429D1 - Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen - Google Patents

Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen

Info

Publication number
DE60035429D1
DE60035429D1 DE60035429T DE60035429T DE60035429D1 DE 60035429 D1 DE60035429 D1 DE 60035429D1 DE 60035429 T DE60035429 T DE 60035429T DE 60035429 T DE60035429 T DE 60035429T DE 60035429 D1 DE60035429 D1 DE 60035429D1
Authority
DE
Germany
Prior art keywords
treatment
inflammatory
sulfode
hydroabetic
endurance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035429T
Other languages
English (en)
Other versions
DE60035429T2 (de
Inventor
Toru Kono
Masafumi Nomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of DE60035429D1 publication Critical patent/DE60035429D1/de
Publication of DE60035429T2 publication Critical patent/DE60035429T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE60035429T 1999-11-11 2000-11-09 Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen Expired - Lifetime DE60035429T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP32105899 1999-11-11
JP32105899 1999-11-11
JP2000225442 2000-07-26
JP2000225442 2000-07-26
PCT/JP2000/007855 WO2001034143A1 (fr) 1999-11-11 2000-11-09 Agents de prevention ou de traitement de maladies inflammatoires de l'intestin

Publications (2)

Publication Number Publication Date
DE60035429D1 true DE60035429D1 (de) 2007-08-16
DE60035429T2 DE60035429T2 (de) 2008-03-06

Family

ID=26570344

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035429T Expired - Lifetime DE60035429T2 (de) 1999-11-11 2000-11-09 Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen

Country Status (17)

Country Link
US (3) US6730702B1 (de)
EP (1) EP1228758B1 (de)
KR (1) KR100526278B1 (de)
CN (1) CN100341497C (de)
AT (1) ATE366107T1 (de)
AU (1) AU773352B2 (de)
CA (1) CA2389032C (de)
CY (1) CY1106763T1 (de)
DE (1) DE60035429T2 (de)
DK (1) DK1228758T3 (de)
ES (1) ES2288878T3 (de)
HK (1) HK1045464A1 (de)
MX (1) MXPA02004707A (de)
NZ (1) NZ518695A (de)
PT (1) PT1228758E (de)
TW (1) TW585762B (de)
WO (1) WO2001034143A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases
EP1380294A1 (de) * 2001-04-17 2004-01-14 Tanabe Seiyaku Co., Ltd. Mittel zur prävention/behandlung von entzündlichen erkrankungen der mundhöhlenschleimhaut und dergleichen
US6831101B2 (en) 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
EP1430892A4 (de) * 2001-09-27 2006-03-01 Tanabe Seiyaku Co Wässrige ecabet-natrium-lösungszubereitung
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
WO2004071453A2 (en) * 2003-02-13 2004-08-26 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
AU2004314731B2 (en) * 2004-01-20 2011-07-07 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
KR100802192B1 (ko) * 2004-07-27 2008-02-11 이병수 한약재를 이용한 발모제 조성물
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
NZ599605A (en) 2007-02-19 2013-11-29 Marinepolymer Tech Inc Hemostatic compositions and therapeutic regimens
KR100963051B1 (ko) 2008-03-14 2010-06-09 광동제약 주식회사 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물
CN101590031B (zh) * 2008-06-17 2011-10-12 浙江爱生药业有限公司 磺化去氢松香酸二钠组合物的制备方法
BR112012025844A2 (pt) 2010-04-15 2017-07-18 Marine Polymer Tech Inc uso de nanofibras snag
ES2712098T3 (es) * 2011-04-15 2019-05-09 Marine Polymer Tech Inc Tratamiento de infecciones por VHS con nanofibras de poli-N-acetilglucosamina
CN104447432B (zh) * 2014-11-21 2018-01-26 珠海亿邦制药股份有限公司 一种新的磺化去氢松香酸铋的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3271037D1 (en) 1981-10-22 1986-06-12 Tanabe Seiyaku Co Salts of sulfodehydroabietic acid and treatment of gastro-intestinal diseases
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
JP3856908B2 (ja) 1997-06-06 2006-12-13 田辺製薬株式会社 褥瘡及び／又は創傷治療剤
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases

Also Published As

Publication number Publication date
MXPA02004707A (es) 2002-09-02
AU773352B2 (en) 2004-05-20
DK1228758T3 (da) 2007-10-29
CY1106763T1 (el) 2012-05-23
KR20020050274A (ko) 2002-06-26
CN100341497C (zh) 2007-10-10
CN1414850A (zh) 2003-04-30
US20040254244A1 (en) 2004-12-16
US20040171686A1 (en) 2004-09-02
ES2288878T3 (es) 2008-02-01
DE60035429T2 (de) 2008-03-06
CA2389032C (en) 2007-05-22
KR100526278B1 (ko) 2005-11-08
EP1228758B1 (de) 2007-07-04
CA2389032A1 (en) 2001-05-17
WO2001034143A1 (fr) 2001-05-17
EP1228758A4 (de) 2004-04-21
AU1302501A (en) 2001-06-06
TW585762B (en) 2004-05-01
PT1228758E (pt) 2007-08-24
ATE366107T1 (de) 2007-07-15
HK1045464A1 (en) 2002-11-29
US7153886B2 (en) 2006-12-26
EP1228758A1 (de) 2002-08-07
US6730702B1 (en) 2004-05-04
NZ518695A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
JO2371B1 (en) 4-phenyl-pyridine derivatives
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
ATE248837T1 (de) Chinuclidin-acrylamide
EE200100558A (et) Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
WO2005056524A3 (en) Therapeutic agents useful for treating pain
DE60205455D1 (de) Naphthyridinderivate
SE9901573D0 (sv) New compounds
DK1396270T3 (da) Borsyresalte
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
IL149586A0 (en) Pyrimidine derivatives as selective inhibitors of cox-2
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
SE0002729D0 (sv) Novel compound form
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
SE9901572D0 (sv) New compounds
DE69930621D1 (de) Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung
GB0019008D0 (en) Therapeutic compounds
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika
SE0301442D0 (sv) Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
WO2005035500A3 (en) Therapeutic agents useful for treating pain

Legal Events

Date Code Title Description
8364 No opposition during term of opposition